ISSN: 2155-9600
+32 25889658
Gerard E Mullin
Johns Hopkins Hospital, USA
Posters & Accepted Abstracts: J Nutr Food Sci
The pathophysiology of obesity is still unknown, however there is mounting evidence that the gut microbiome, intestinal permeability, systemic inflammation, cytokines, subclinical endotoxemia and insulin resistance may play important roles in disease pathogenesis and are possibly targets for treatment. Alterations in diet have been shown to shift the gut microbiome�?¢�?�?�?�?s effects on metabolism and regulation of body weight by a number of mechanisms that involve the gut microbiome. This session will provide a focused overview of the scientific literature regarding the potential role of gut microbiome as a therapeutic target of weight management and cardiometabolic health. The lecture will first review the pathophysiology of obesity and discuss how an evidencebased approach can achieve optimal weight management by dietary manipulation of the gut microbiome along with prebiotics and probiotics. Learning objectives: To discuss the influence of the gut microbiome on energy metabolism; to understand how disruption of the gut microbiome can lead to obesity; to know how prebiotic and probiotic foods and supplements may influence weight by favorably altering the gut microbiome.
Email: gmullin1@jhmi.edu